# 21 U.S.C. 360eee Definitions

21 U.S.C. 360eee Definitions, “Definitions”, is a U.S. Code section of [Part H—Pharmaceutical Distribution Supply Chain](https://ontology.bommaritollc.com/id/01a0f06c-cb9e-7162-acbf-050ccaf8b4de); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f06c-cd5a-716b-a5a3-e0ffc4ddef5c>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f06c-cb65-7672-8fda-c39517ff08c0) › [Chapter 9—Federal Food, Drug, and Cosmetic Act](https://ontology.bommaritollc.com/id/01a0f06c-cb91-72e0-858b-060e8c845f23) › [Subchapter V—Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb96-7040-b454-c8f18e0e95cb) › [Part H—Pharmaceutical Distribution Supply Chain](https://ontology.bommaritollc.com/id/01a0f06c-cb9e-7162-acbf-050ccaf8b4de)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [usc-section 21 U.S.C. 360eee](https://ontology.bommaritollc.com/id/01a0f06c-cd5c-74b0-aaf8-3aaef487e8bf)
- `eli:cites`:
  - [Part A—Introductory Provisions](https://ontology.bommaritollc.com/id/01a0f06c-cbc0-72df-802d-7de73b6bdab0)
  - [21 U.S.C. 321 Definitions; generally](https://ontology.bommaritollc.com/id/01a0f06c-cc8c-7030-ab68-1def0b197dcb)
  - [21 U.S.C. 353 Exemptions and consideration for certain drugs, devices, and biological products](https://ontology.bommaritollc.com/id/01a0f06c-cccb-7545-90e2-a1651be32192)
  - [21 U.S.C. 353a Pharmacy compounding](https://ontology.bommaritollc.com/id/01a0f06c-cccc-7239-a12d-7fdd95ff8460)
  - [21 U.S.C. 353b Outsourcing facilities](https://ontology.bommaritollc.com/id/01a0f06c-ccd0-70b8-a786-21b4a54612de)
  - [21 U.S.C. 355 New drugs](https://ontology.bommaritollc.com/id/01a0f06c-ccd6-7038-b7ea-5f9e1b3b3f50)
  - [21 U.S.C. 360 Registration of producers of drugs or devices](https://ontology.bommaritollc.com/id/01a0f06c-ccfb-75a5-8f8d-2899cf8ac727)
  - [21 U.S.C. 360b New animal drugs](https://ontology.bommaritollc.com/id/01a0f06c-cd00-76d9-bb38-b67fe8155231)
  - [21 U.S.C. 360ddd Definitions](https://ontology.bommaritollc.com/id/01a0f06c-cd56-74a8-ad45-d57ebf8fce47)
  - [21 U.S.C. 360eee-1 Requirements](https://ontology.bommaritollc.com/id/01a0f06c-cd5c-74b0-aaf8-3ab0d22128bc)
  - [21 U.S.C. 360eee-2 National standards for prescription drug wholesale distributors](https://ontology.bommaritollc.com/id/01a0f06c-cd5d-74a4-b580-c321d0f854be)
  - [21 U.S.C. 360eee-3 National standards for third-party logistics providers](https://ontology.bommaritollc.com/id/01a0f06c-cd5e-750e-855e-9e85a5bf6dcb)
  - [26 U.S.C. 501 Exemption from tax on corporations, certain trusts, etc.](https://ontology.bommaritollc.com/id/01a0f071-2045-73e4-b918-7af09614eb5f)
  - [42 U.S.C. 247d Public health emergencies](https://ontology.bommaritollc.com/id/01a0f07c-d961-7148-9e7e-f0bbd971a175)
  - [42 U.S.C. 262 Regulation of biological products](https://ontology.bommaritollc.com/id/01a0f07c-d9ca-7203-a1d8-2d79c0329140)
  - [42 U.S.C. 2021 Cooperation with States](https://ontology.bommaritollc.com/id/01a0f07c-e4e0-74e6-8035-bfebf0f0110c)
  - [21 CFR 600.3 Definitions.](https://ontology.bommaritollc.com/id/01a0f094-cb20-72fd-bc6b-96a966ba080d)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapV-partH-sec360eee](https://ontology.bommaritollc.com/id/01a0f06c-cd5a-716b-a5a3-e0fed6a8e7e7)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f06c-d16b-7773-948b-980c3b3b9304)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d2-2d9d-76f1-b4f8-dcb815192491)
  - [evidence from https://www.govinfo.gov/link/uscode/21/360eee?type=usc&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f15-fe42-76f5-b6e3-faefdd100170)
- `schema:isPartOf`: [Part H—Pharmaceutical Distribution Supply Chain](https://ontology.bommaritollc.com/id/01a0f06c-cb9e-7162-acbf-050ccaf8b4de)
- `schema:legislationIdentifier`: 21 U.S.C. 360eee
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [U.S. Code section](https://ontology.bommaritollc.com/vocab/leg/uscSection)
- `schema:name`: Definitions
- `schema:url`: [https://www.govinfo.gov/link/uscode/21/360eee?type=usc&year=mostrecent&link-type=details](https://www.govinfo.gov/link/uscode/21/360eee?type=usc&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 U.S.C. 360eee Definitions

## Elsewhere

- [Official page](https://www.govinfo.gov/link/uscode/21/360eee?type=usc&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapV-partH-sec360eee) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Rules made under it (6; `eli:based_on`):
  - [21 CFR Part 3—Product jurisdiction](https://ontology.bommaritollc.com/id/01a0f094-b7dc-7010-b821-be4791210aae)
  - [21 CFR Part 50—Protection of human subjects](https://ontology.bommaritollc.com/id/01a0f094-b7f0-7092-8cfc-6d60da0417f5)
  - [21 CFR Part 56—Institutional Review Boards](https://ontology.bommaritollc.com/id/01a0f094-b7f2-72a4-82d6-ac180848fce4)
  - [21 CFR Part 601—Licensing](https://ontology.bommaritollc.com/id/01a0f094-b882-764a-a051-b44410b6e848)
  - [21 CFR Part 740—Cosmetic product warning statements](https://ontology.bommaritollc.com/id/01a0f094-b88d-71bd-8d90-cd0e83729420)
  - [21 CFR Part 812—Investigational device exemptions](https://ontology.bommaritollc.com/id/01a0f094-b896-7341-a342-c3a0aea5ee4f)
- Cited by (3; `eli:cites`):
  - [21 U.S.C. 353 Exemptions and consideration for certain drugs, devices, and biological products](https://ontology.bommaritollc.com/id/01a0f06c-cccb-7545-90e2-a1651be32192)
  - [21 U.S.C. 360eee-1 Requirements](https://ontology.bommaritollc.com/id/01a0f06c-cd5c-74b0-aaf8-3ab0d22128bc)
  - [21 U.S.C. 360eee-4 Uniform national policy](https://ontology.bommaritollc.com/id/01a0f06c-cd5f-727a-a240-333cf1b76198)
- Its changes, from (1; `eli:changes`):
  - [Pub. L. 113-54](https://ontology.bommaritollc.com/id/01a0f06c-d2e5-71cb-81a3-ce61403ee6bc)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f06c-cd5a-716b-a5a3-e0ffc4ddef5c.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f06c-cd5a-716b-a5a3-e0ffc4ddef5c.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f06c-cd5a-716b-a5a3-e0ffc4ddef5c.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f06c-cd5a-716b-a5a3-e0ffc4ddef5c)
Cite as: 21 U.S.C. 360eee Definitions. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f06c-cd5a-716b-a5a3-e0ffc4ddef5c
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
